A Systematic Review and Meta‐Analysis of Placebo‐Controlled Antidepressant Studies in People with Depression and Dementia

@article{Nelson2011ASR,
  title={A Systematic Review and Meta‐Analysis of Placebo‐Controlled Antidepressant Studies in People with Depression and Dementia},
  author={James Craig Nelson and Davangere P. Devanand},
  journal={Journal of the American Geriatrics Society},
  year={2011},
  volume={59}
}
  • J. Nelson, D. Devanand
  • Published 1 April 2011
  • Psychology, Medicine
  • Journal of the American Geriatrics Society
OBJECTIVES: To determine the efficacy of antidepressants in people with depression and dementia. 
View on Wiley
ncbi.nlm.nih.gov
267 Citations
Highly Influential Citations
10
Background Citations
53
Methods Citations
6
Results Citations
11

267 Citations

Citation Type

Citation Type

Effects of a high‐intensity functional exercise program on depressive symptoms among people with dementia in residential care: a randomized controlled trial
The aim of this study is to evaluate the effect of a high‐intensity functional exercise program on depressive symptoms among older care facility residents with dementia.
Depression in older people with and without dementia : non-pharmacological interventions and associations between psychotropic drugs and mortality
The aim of this thesis was to investigate associations between psychotropic drug use and death, associations between functional capacity, dependency in ADL and depression, and to evaluate a non-pha…
Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry
TLDR
The association between mortality risk and use of antidepressants in people with dementia is unknown and the number of antidepressant prescriptions used and the severity of dementia are unknown.
What is the therapeutic value of antidepressants in dementia? A narrative review
TLDR
The aim of this narrative review is to summarize the evidence on whether there is therapeutic value in prescribing antidepressants to people with dementia.
Inclusion/exclusion criteria in late life depression antidepressant efficacy trials
The generalizability of antidepressant efficacy trials (AETs) has been questioned. No studies have examined the inclusion/exclusion criteria used in placebo‐controlled studies of late life depression…
What is the role of medications in late life depression?
  • R. Kok
  • Psychology, Medicine
    The Psychiatric clinics of North America
  • 2013
The diagnosis of depression and use of antidepressants in nursing home residents with and without dementia
TLDR
To compare the prevalence of diagnosed depressive disorders, depressive symptoms and use of antidepressant medication between nursing home residents with and without dementia, a large number of residents with dementia and those without dementia are compared.
Efficacy of pain treatment on mood syndrome in patients with dementia: a randomized clinical trial
TLDR
The association between pain and depressive symptoms has been reported, but the impact of pain management on depression and other mood symptoms has not been investigated.
Psychological treatment for depression and anxiety associated with dementia and mild cognitive impairment
TLDR
A systematic review of psychological treatments that appears in this issue of the Journal highlights the current paucity of good-quality data, but suggests these interventions hold promise.
International study on antidepressant prescription pattern at 40 major psychiatric institutions and hospitals in Asia: A 10‐year comparison study
TLDR
This study aims to compare the antidepressants prescription pattern in Asia in 2003–2004 and 2013 and finds that antidepressant prescriptions in Asia have changed little since 2003.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
A double‐blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia
TLDR
To compare the efficacy of paroxetine and imipramine prospectively in patients with coexisting depression and dementia prospectively is compared.
Antidepressant Drug Effects and Depression Severity
Context Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to…
A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia
TLDR
Results of ratings on the Gottfries‐Bråne‐Steen dementia rating scale indicated that both cognitive and emotional functioning improved significantly more in the citalopram‐ treated subgroup of patients with dementia than in the placebo‐treated subgroup.
Efficacy and Safety of Antidepressants for Treatment of Depression in Alzheimer's Disease: A Metaanalysis
TLDR
Antidepressant treatment for depression in AD is efficacious, with rates of discontinuation that are comparable to placebo, Nonetheless, clinicians must be vigilant regarding the potential side effects of antidepressants in this population.
Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
TLDR
Sertraline is superior to placebo for the treatment of major depression in Alzheimer disease and depression reduction is accompanied by lessened behavior disturbance and improved activities of daily living, but not improved cognition.
Placebo response in studies of major depression: variable, substantial, and growing.
TLDR
The response to placebo in published trials of antidepressant medication for MDD is highly variable and often substantial and has increased significantly in recent years, as has the response to medication.
A Double-Blind, Placebo-Controlled Study of Fluoxetine in Depressed Patients With Alzheimer's Disease
TLDR
Both the fluoxetine and the placebo groups showed a significant decline in HAM-D scores over time, but the magnitude of mood improvement was similar for both groups, confirming the presence of a placebo effect in the treatment of depression in AD.
Sertraline for the treatment of depression in Alzheimer disease.
  • P. Rosenberg, Lea T. Drye, C. Lyketsos
  • Psychology, Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2010
TLDR
Sertraline did not demonstrate efficacy for the treatment depression symptoms in patients with AD, and its use was associated with an increased incidence of adverse events, suggesting selective serotonin reuptake inhibitors may be of limited value for treating depression in Patients with AD.
Antidepressant drug effects and depression severity: a patient-level meta-analysis.
TLDR
The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms.
Double-blind trial of imipramine in Alzheimer's disease patients with and without depression.
TLDR
The results suggest that moderate depression is a treatable condition in patients with Alzheimer's disease.
...
1
2
3
4
5
...